Lantus Dose Adjustment Recommendation
Increase the Lantus dose from 8 units to 10 units daily, then continue titrating by 2 units every 3 days until the fasting blood glucose reaches ≤110 mg/dL (ideally ≤100 mg/dL). 11
Rationale for This Recommendation
Your patient's fasting blood glucose of 184 mg/dL is significantly above target (goal: ≤110 mg/dL, ideally ≤100 mg/dL), indicating inadequate basal insulin coverage. The current dose of 8 units is below the standard starting dose and requires systematic up-titration.
Evidence-Based Titration Algorithm
The 2025 American Diabetes Association Standards of Care provide clear guidance 11:
- Standard titration approach: Increase by 2 units every 3 days to reach fasting plasma glucose goal without hypoglycemia
- This is the most widely validated and safest approach for outpatient titration
- Continue this pattern until fasting glucose consistently reaches ≤110 mg/dL
Why Start at 10 Units?
The FDA-approved Lantus prescribing information 22 specifies that the recommended starting dose for type 2 diabetes patients not currently on insulin is 10 units (or 0.2 Units/kg) once daily. Since your patient is on only 8 units—below the standard starting dose—an immediate increase to 10 units is appropriate before beginning the systematic titration protocol.
Practical Implementation Steps
- Immediate adjustment: Increase from 8 to 10 units today
- Monitor fasting glucose for 3 days
- If fasting glucose remains >110 mg/dL: Increase by 2 units
- Repeat every 3 days until target achieved
- Hold or reduce dose by 10-20% if hypoglycemia occurs (blood glucose <70 mg/dL) 11
Alternative Titration Options (If Faster Control Needed)
If more aggressive titration is clinically warranted based on A1C >10% or symptoms of hyperglycemia, consider the Treat-to-Target algorithm 3:
- Increase by 2 units if fasting glucose 120-140 mg/dL
- Increase by 4 units if fasting glucose 140-180 mg/dL
- Increase by 6-8 units if fasting glucose ≥180 mg/dL
However, the standard 2-unit every-3-days approach 11 is safer for most patients and minimizes hypoglycemia risk.
Critical Safety Considerations
- Hypoglycemia risk: The most common adverse reaction with Lantus 2. If blood glucose drops <70 mg/dL, reduce dose by 10-20% 1
- Patient education: Ensure the patient recognizes hypoglycemia symptoms and has glucose monitoring capability
- Timing consistency: Lantus must be given at the same time each day 22
- Do not mix or dilute: Lantus should never be mixed with other insulins 2
Expected Outcomes
With systematic titration, most patients achieve fasting glucose targets within 3-5 days per dose adjustment 4. Given the current fasting glucose of 184 mg/dL, expect to need several dose increases (likely reaching 16-20 units total) before achieving consistent control.